Details

The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry


The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry


1. Aufl.

von: David M. Taylor, Fiona Gaughran, Toby Pillinger

42,99 €

Verlag: Wiley-Blackwell
Format: PDF
Veröffentl.: 09.10.2020
ISBN/EAN: 9781119554219
Sprache: englisch
Anzahl Seiten: 752

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

<p><b>Learn to im</b><b>prove your assessment, investigation, and management of physical health conditions in people with severe mental illness</b> </p> <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i><i> </i>offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill.  </p> <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry </i>also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner.   </p> <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry </i>covers the following: </p> <ul style="margin-bottom: 0in; font-size: medium; margin-top: 0in; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; cursor: text; overflow: visible;" type="disc"> <li style="margin: 0in 0in 0.0001pt 0.25in; font-size: 11pt; font-family: Calibri, sans-serif; vertical-align: baseline; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; cursor: text; overflow: visible;">Guidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness </li> <li style="margin: 0in 0in 0.0001pt 0.25in; font-size: 11pt; font-family: Calibri, sans-serif; vertical-align: baseline; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; cursor: text; overflow: visible;">Management of physical health emergencies in a psychiatric setting </li> <li style="margin: 0in 0in 0.0001pt 0.25in; font-size: 11pt; font-family: Calibri, sans-serif; vertical-align: baseline; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; cursor: text; overflow: visible;">Evidence-based approaches to management of physical side effects of psychiatric medications </li> <li style="margin: 0in 0in 0.0001pt 0.25in; font-size: 11pt; font-family: Calibri, sans-serif; vertical-align: baseline; user-select: text; -webkit-user-drag: none; -webkit-tap-highlight-color: transparent; cursor: text; overflow: visible;">Advice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity </li> </ul> <p>Perfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, <i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i> will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.  </p> <p> </p>
<p><b>TABLE OF CONTENTS</b><br /><br />Preface xxi</p> <p>List of abbreviations xxiii</p> <p> </p> <p><b>Part 1 Cardiology 1</b></p> <p><b> </b></p> <p><b>Chapter 1 Tachycardia 3</b></p> <p>Sinus tachycardia 3</p> <p>Atrial fibrillation 4</p> <p>Supraventricular tachycardia 4</p> <p>Ventricular tachycardia 6</p> <p>Diagnostic principles 6</p> <p>Management 10</p> <p>References 14</p> <p><b> </b></p> <p><b>Chapter 2 Bradycardia 17</b></p> <p>Diagnosis 19</p> <p>Management and when to refer to a specialist 21</p> <p>References 22</p> <p><b> </b></p> <p><b>Chapter 3 QT Interval Prolongation 23</b></p> <p>Prescribing QTc‐prolonging medication 27</p> <p>Diagnostic principles 28</p> <p>Management 29</p> <p>References 32</p> <p><b> </b></p> <p><b>Chapter 4 Syncope 35</b></p> <p>Causes of syncope 35</p> <p>Syncope and serious mental illness 36</p> <p>Diagnostic principles 36</p> <p>Diagnosis and management 38</p> <p>References 39</p> <p><b> </b></p> <p><b>Chapter 5 Hypertension 41</b></p> <p>Diagnostic principles 43</p> <p>Diagnosis 44</p> <p>Management 45</p> <p>References 48</p> <p><b> </b></p> <p><b>Chapter 6 Postural Hypotension 51</b></p> <p>Diagnostic principles 53</p> <p>Management 54</p> <p>References 58</p> <p><b> </b></p> <p><b>Chapter 7 Peripheral Oedema 59</b></p> <p>Diagnostic principles 60</p> <p>Management 66</p> <p>References 67</p> <p><b> </b></p> <p><b>Chapter 8 Myocarditis 71</b></p> <p>Diagnostic principles 71</p> <p>Management 75</p> <p>Clozapine‐induced myocarditis 75</p> <p>References 77</p> <p><b> </b></p> <p><b>Chapter 9 Hypercholesterolaemia 79</b></p> <p>Diagnostic principles 80</p> <p>Diagnostic criteria 81</p> <p>Management 81</p> <p>References 84</p> <p><b> </b></p> <p><b>Chapter 10 Physical Activity 85</b></p> <p>Physical activity and serious mental illness 85</p> <p>How much physical activity and exercise should people be doing? 86</p> <p>Practical tips 87</p> <p>Messages to include in discussions with patients 87</p> <p>References 88</p> <p><b> </b></p> <p><b>Part 2 Endocrinology 91</b></p> <p><b> </b></p> <p><b>Chapter 11 Diabetes Mellitus 93</b></p> <p>Diagnostic principles 93</p> <p>Management 97</p> <p>References 102</p> <p><b> </b></p> <p><b>Chapter 12 Thyroid Disease 105</b></p> <p>Hypothyroidism 105</p> <p>Diagnostic principles 107</p> <p>Management 110</p> <p>Hyperthyroidism 111</p> <p>Diagnostic principles 112</p> <p>Management 113</p> <p>References 114</p> <p><b> </b></p> <p><b>Chapter 13 Hyperprolactinaemia 117</b></p> <p>Diagnostic principles 119</p> <p>Management and when to refer to a specialist 121</p> <p>Hyperprolactinaemia and osteoporosis risk in serious mental illness 122</p> <p>Hyperprolactinaemia and cancer risk 123</p> <p>References 123</p> <p><b> </b></p> <p><b>Chapter 14 Obesity 125</b></p> <p>Monitoring 127</p> <p>Prevention and treatment of weight gain 129</p> <p>References 134</p> <p><b> </b></p> <p><b>Part 3 Haematology 137</b></p> <p><b> </b></p> <p><b>Chapter 15 Anaemia 139</b></p> <p>Diagnostic principles 140</p> <p>Management and referral pathways 143</p> <p>References 145</p> <p><b> </b></p> <p><b>Chapter 16 Neutropenia 147</b></p> <p>Drug‐induced neutropenia and agranulocytosis 149</p> <p>Diagnostic principles 150</p> <p>Management 151</p> <p>References 153</p> <p><b> </b></p> <p><b>Chapter 17 Thrombocytopenia 155</b></p> <p>Diagnostic principles 156</p> <p>Management and when to refer 158</p> <p>References 158</p> <p><b> </b></p> <p><b>Chapter 18 Venous Thromboembolism and Anticoagulation 159</b></p> <p>Risk factors 159</p> <p>Prophylaxis 161</p> <p>Diagnosis 162</p> <p>Management 164</p> <p>References 168</p> <p><b> </b></p> <p><b>Part 4 Gastroenterology 169</b></p> <p><b> </b></p> <p><b>Chapter 19 Gastro‐oesophageal Reflux and Peptic Ulcer Disease 171</b></p> <p>Gastro‐oesophageal reflux disease 171</p> <p>Peptic ulcer disease 176</p> <p>References 178</p> <p> </p> <p><b>Chapter 20 Gastrointestinal Bleeding 181</b></p> <p>Diagnostic principles 183</p> <p>Management 185</p> <p>References 188</p> <p><b> </b></p> <p><b>Chapter 21 Nausea and Vomiting 191</b></p> <p>Diagnostic principles 193</p> <p>Management 195</p> <p>References 198</p> <p><b> </b></p> <p><b>Chapter 22 Dysphagia 199</b></p> <p>Causes of dysphagia in the general population 199</p> <p>Diagnostic principles 200</p> <p>Management 203</p> <p>Oesophageal cancer in psychiatric populations 203</p> <p>Dysphagia in the elderly 204</p> <p>References 204</p> <p><b> </b></p> <p><b>Chapter 23 Deranged Liver Function Tests 207</b></p> <p>Diagnostic principles 207</p> <p>Management 212</p> <p>References 213</p> <p><b> </b></p> <p><b>Chapter 24 Alcohol and Physical Health 215</b></p> <p>What is harmful use? 215</p> <p>Physical complications of alcohol use 216</p> <p>Approach to the patient with suspected alcohol misuse 217</p> <p>Management 220</p> <p>References 222</p> <p><b> </b></p> <p><b>Chapter 25 Unintentional Weight Loss 223</b></p> <p>Diagnostic principles 225</p> <p>Management 227</p> <p>References 227</p> <p><b> </b></p> <p><b>Chapter 26 Dry Mouth 229</b></p> <p>Diagnostic principles 231</p> <p>Management 231</p> <p>References 232</p> <p><b> </b></p> <p><b>Chapter 27 Hypersalivation 235</b></p> <p>Diagnostic principles 235</p> <p>Management 236</p> <p>References 239</p> <p> </p> <p><b>Chapter 28 Constipation 241</b></p> <p>Diagnostic principles 243</p> <p>Management 244</p> <p>References 249</p> <p><b> </b></p> <p><b>Part 5 Renal and Urology 251</b></p> <p><b> </b></p> <p><b>Chapter 29 Urinary Retention 253</b></p> <p>Urinary retention and serious mental illness 253</p> <p>Diagnostic principles 254</p> <p>Management 256</p> <p>References 256</p> <p><b> </b></p> <p><b>Chapter 30 Urinary Incontinence 259</b></p> <p>Diagnostic principles 261</p> <p>Management 262</p> <p>References 264</p> <p><b> </b></p> <p><b>Chapter 31 Polyuria 267</b></p> <p>Diagnostic principles 268</p> <p>Management 269</p> <p>References 271</p> <p><b> </b></p> <p><b>Chapter 32 Sodium Derangement 273</b></p> <p>Diagnostic principles 274</p> <p>Management 276</p> <p>References 277</p> <p><b> </b></p> <p><b>Chapter 33 Potassium Derangement 279</b></p> <p>Hyperkalaemia 279</p> <p>Hypokalaemia 282</p> <p>References 285</p> <p><b> </b></p> <p><b>Chapter 34 Chronic Kidney Disease 287</b></p> <p>Diagnostic principles 289</p> <p>Management 291</p> <p>References 295</p> <p><b> </b></p> <p><b>Part 6 Sexual and Reproductive Health 297</b></p> <p><b> </b></p> <p><b>Chapter 35 Sexual Dysfunction 299</b></p> <p>Assessment of a patient with sexual dysfunction 299</p> <p>Management 301</p> <p>References 304</p> <p> </p> <p><b>Chapter 36 Contraception 307</b></p> <p>Clinical approach 308</p> <p>Contraceptive options 308</p> <p>Ethical and legal considerations 312</p> <p>When to refer 313</p> <p>Special considerations in patients with serious mental illness 313</p> <p>References 314</p> <p><b> </b></p> <p><b>Chapter 37 Infertility 317</b></p> <p>Addressing infertility in psychiatric practice 317</p> <p>Onward referral and further tests for infertility 318</p> <p>Infertility treatments 318</p> <p>References 318</p> <p><b> </b></p> <p><b>Chapter 38 Sexually Transmitted Infection 319</b></p> <p>History 319</p> <p>STI testing in psychiatry 320</p> <p>Determining urgency of clinical action/referral 321</p> <p>Referral to sexual health services 322</p> <p>References 324</p> <p><b> </b></p> <p><b>Part 7 Infectious Diseases 325</b></p> <p><b> </b></p> <p><b>Chapter 39 Pneumonia 327</b></p> <p>Pneumonia and serious mental illness 329</p> <p>Diagnostic principles 329</p> <p>Management 332</p> <p>References 335</p> <p><b> </b></p> <p><b>Chapter 40 Influenza 337</b></p> <p>Diagnostic principles 338</p> <p>Management 339</p> <p>Preventing spread of influenza 341</p> <p>References 342</p> <p><b> </b></p> <p><b>Chapter 41 Urinary Tract Infection 343</b></p> <p>Urinary tract infection and serious mental illness 344</p> <p>Diagnostic principles 344</p> <p>Management 347</p> <p>References 350</p> <p><b> </b></p> <p><b>Chapter 42 Gastroenteritis 251</b></p> <p>Diagnostic principles 251</p> <p>Management 254</p> <p>References 256</p> <p> </p> <p><b>Chapter 43 Viral Hepatitis 357</b></p> <p>Hepatitis B 357</p> <p>Hepatitis C 361</p> <p>References 364</p> <p><b> </b></p> <p><b>Chapter 44 Tuberculosis 365</b></p> <p>Diagnostic principles 366</p> <p>Management 369</p> <p>References 371</p> <p><b> </b></p> <p><b>Chapter 45 Human Immunodeficiency Virus 373</b></p> <p>Testing for HIV 374</p> <p>HIV and the central nervous system 374</p> <p>Antiretroviral therapy 375</p> <p>References 380</p> <p><b> </b></p> <p><b>Part 8 Respiratory 383</b></p> <p><b> </b></p> <p><b>Chapter 46 Smoking Cessation 385</b></p> <p>Identifying those who want to stop smoking and degree</p> <p>of nicotine dependence 385</p> <p>Approaches to smoking cessation 387</p> <p>References 392</p> <p><b> </b></p> <p><b>Chapter 47 Chronic Obstructive Pulmonary Disease 395</b></p> <p>Common causes of COPD in the general population and patients</p> <p>with serious mental illness 395</p> <p>The asthma–COPD overlap 396</p> <p>Diagnostic principles 397</p> <p>Management 400</p> <p>References 403</p> <p><b> </b></p> <p><b>Chapter 48 Asthma 405</b></p> <p>Causes in the general population and people with serious</p> <p>mental illness 405</p> <p>Diagnostic principles 406</p> <p>Management 409</p> <p>References 412</p> <p><b> </b></p> <p><b>Chapter 49 Obstructive Sleep Apnoea 413</b></p> <p>Diagnostic principles 414</p> <p>Management 415</p> <p>References 416</p> <p><b> </b></p> <p><b>Part 9 Neurology 419</b></p> <p><b> </b></p> <p><b>Chapter 50 Delirium 421</b></p> <p>Diagnostic principles421</p> <p>Management 426</p> <p>References 429</p> <p><b> </b></p> <p><b>Chapter 51 Autoimmune Encephalitis 431</b></p> <p>Autoimmune disease mechanisms 431</p> <p>Clinical approach 432</p> <p>Management 437</p> <p>References 439</p> <p><b> </b></p> <p><b>Chapter 52 Catatonia 441</b></p> <p>Diagnostic principles 442</p> <p>Management 444</p> <p>References 448</p> <p><b> </b></p> <p><b>Chapter 53 Seizure Disorders 451</b></p> <p>Acute seizure 452</p> <p>Psychiatric comorbidity in people with epilepsy 455</p> <p>Psychiatric side effects of antiepileptic drugs 457</p> <p>Psychiatric drug therapy in people with epilepsy 457</p> <p>Psychogenic non‐epileptic seizures 458</p> <p>Epilepsy surgery 459</p> <p>Epilepsy and learning disability 459</p> <p>References 459</p> <p><b> </b></p> <p><b>Chapter 54 Headache 461</b></p> <p>Diagnostic principles 463</p> <p>Management 466</p> <p>References 468</p> <p><b> </b></p> <p><b>Chapter 55 Disorders of Sleep and Circadian Rhythm 471</b></p> <p>Definitions of common sleep disorders in psychiatric</p> <p>populations 471</p> <p>Diagnostic principles 474</p> <p>Management 476</p> <p>References 477</p> <p><b> </b></p> <p><b>Chapter 56 Extrapyramidal Side Effects 479</b></p> <p>Clinical approach 480</p> <p>Management 482</p> <p>References 483</p> <p><b> </b></p> <p><b>Chapter 57 Tardive Dyskinesia 485</b></p> <p>Clinical approach 486</p> <p>Management 487</p> <p>References 489</p> <p><b> </b></p> <p><b>Chapter 58 Tremor 491</b></p> <p>Clinical approach 491</p> <p>Management 494</p> <p>References 496</p> <p><b> </b></p> <p><b>Part 10 Rheumatology and Musculoskeletal Health 497</b></p> <p><b> </b></p> <p><b>Chapter 59 Low Back Pain 499</b></p> <p>Diagnostic principles 500</p> <p>Management 502</p> <p>References 503</p> <p><b> </b></p> <p><b>Chapter 60 Arthritis 505</b></p> <p>Clinical approach 510</p> <p>Management 512</p> <p>References 512</p> <p><b> </b></p> <p><b>Part 11 Ophthalmology 515</b></p> <p><b> </b></p> <p><b>Chapter 61 Eye Disease 517</b></p> <p>Clinical approach to a patient with visual disturbance or</p> <p>orbital/periorbital disorders 517</p> <p>Disorders of the eyelids 522</p> <p>Disorders of the conjunctiva 526</p> <p>Disorders of the cornea 529</p> <p>References 533</p> <p><b> </b></p> <p><b>Part 12 Obstetrics and Gynaecology 535</b></p> <p><b> </b></p> <p><b>Chapter 62 Pregnancy 537</b></p> <p>The pre‐conception period 538</p> <p>During pregnancy 539</p> <p>Psychiatric medication in pregnancy 543</p> <p>Postpartum psychosis 547</p> <p>Electroconvulsive therapy in pregnancy 547</p> <p>References 548</p> <p><b> </b></p> <p><b>Chapter 63 Menopause 551</b></p> <p>Physiology and symptoms of perimenopause 551</p> <p>Clinical approach 552</p> <p>Treatment 553</p> <p>References 556</p> <p><b> </b></p> <p><b>Part 13 Dermatology 559</b></p> <p><b> </b></p> <p><b>Chapter 64 General Dermatology 561</b></p> <p>Infectious skin disease 561</p> <p>Non‐infectious skin disease 564</p> <p>References 566</p> <p><b> </b></p> <p><b>Chapter 65 Psychodermatology 569</b></p> <p>Psychiatric disorders with skin manifestations 569</p> <p>Psychophysiological conditions 571</p> <p>Secondary psychological disorders 571</p> <p>Cutaneous sensory disorders 572</p> <p>References 572</p> <p><b> </b></p> <p><b>Part 14 Electroconvulsive Therapy 573</b></p> <p><b> </b></p> <p><b>Chapter 66 Electroconvulsive Therapy 575</b></p> <p>Indications and contraindications 575</p> <p>The ECT procedure 576</p> <p>Physiological effects of ECT 576</p> <p>Pre‐ECT assessment 578</p> <p>Safety of ECT 579</p> <p>ECT prescribing 579</p> <p>Guidance for the doctor administering ECT 579</p> <p>Side effects of ECT 580</p> <p>Special patient groups 581</p> <p>References 581</p> <p><b> </b></p> <p><b>Part 15 Emergencies 583</b></p> <p><b> </b></p> <p><b>Chapter 67 Chest pain 585</b></p> <p>Diagnostic principles 586</p> <p>Management 590</p> <p>Information to provide in a ‘chest pain’ referral to medical services 591</p> <p>References 591</p> <p><b> </b></p> <p><b>Chapter 68 Acute Shortness of Breath 593</b></p> <p>Diagnostic principles 593</p> <p>Management 595</p> <p>References 596</p> <p><b> </b></p> <p><b>Chapter 69 Acute Coronary Syndrome 597</b></p> <p>Diagnostic principles 598</p> <p>Management 602</p> <p>References 603</p> <p> </p> <p><b>Chapter 70 Arrhythmia 605</b></p> <p>Tachycardia 605</p> <p>Bradycardia 605</p> <p>Reference 608</p> <p><b> </b></p> <p><b>Chapter 71 Hypertensive Crisis 609</b></p> <p>Diagnostic principles 609</p> <p>Management 610</p> <p>References 611</p> <p><b> </b></p> <p><b>Chapter 72 Sepsis 613</b></p> <p>When to think sepsis 613</p> <p>Septic shock 614</p> <p>Management 614</p> <p>Post‐sepsis syndrome 615</p> <p>References 616</p> <p><b> </b></p> <p><b>Chapter 73 Acute Kidney Injury 617</b></p> <p>Categorisation of acute kidney injury 617</p> <p>Diagnostic principles 620</p> <p>Management 622</p> <p>Psychiatric medication and acute kidney injury 622</p> <p>References 623</p> <p><b> </b></p> <p><b>Chapter 74 Diabetic Emergencies 625</b></p> <p>Hypoglycaemia 625</p> <p>Diabetic ketoacidosis 626</p> <p>Hyperosmolar hyperglycaemic state 627</p> <p>References 627</p> <p><b> </b></p> <p><b>Chapter 75 Acute Upper Gastrointestinal Bleeding 629</b></p> <p>Signs of acute upper gastrointestinal bleeding 629</p> <p>Waiting for transfer 629</p> <p>Handing over to the acute medical team 630</p> <p><b> </b></p> <p><b>Chapter 76 Status Epilepticus 631</b></p> <p><b> </b></p> <p><b>Chapter 77 Anaphylaxis 633</b></p> <p>Management 633</p> <p>References 636</p> <p><b> </b></p> <p><b>Chapter 78 Reduced Consciousness and Coma 637</b></p> <p>Clinical approach 637</p> <p>References 640</p> <p><b> </b></p> <p><b>Chapter 79 Thyroid Emergencies 641</b></p> <p>Hypothyroid crisis/myxoedema coma 641</p> <p>Hyperthyroid crisis/thyroid storm 642</p> <p>References 643</p> <p><b> </b></p> <p><b>Chapter 80 Head Injury 645</b></p> <p>Clinical approach 645</p> <p>Types of intracranial haemorrhage 649</p> <p>References 650</p> <p><b> </b></p> <p><b>Chapter 81 Acute Meningitis and Infective Encephalitis 651</b></p> <p>Meningitis 651</p> <p>Infective encephalitis 653</p> <p>References 655</p> <p><b> </b></p> <p><b>Chapter 82 Stroke and Transient Ischaemic Attack 657</b></p> <p>Stroke 657</p> <p>Diagnostic principles 658</p> <p>Management 659</p> <p>Transient Ischaemic Attack 660</p> <p>Diagnostic principles 660</p> <p>Management 661</p> <p>References 661</p> <p><b> </b></p> <p><b>Chapter 83 Overdose 663</b></p> <p>General principles 663</p> <p>Information gathering 664</p> <p>Emergency assessment and management 664</p> <p>Specific scenarios 667</p> <p>Management of a person who refuses admission to hospital</p> <p>after an overdose 670</p> <p>References 670</p> <p><b> </b></p> <p><b>Chapter 84 Acute Dystonia 673</b></p> <p>Diagnostic principles 673</p> <p>Management 675</p> <p>References 677</p> <p><b> </b></p> <p><b>Chapter 85 Neuroleptic Malignant Syndrome 679</b></p> <p>Diagnostic principles 679</p> <p>Management 680</p> <p>References 681</p> <p><b> </b></p> <p><b>Chapter 86 Serotonin Syndrome 683</b></p> <p>Diagnostic principles 683</p> <p>Management 684</p> <p>References 685</p> <p><b> </b></p> <p><b>Chapter 87 Emergencies in Obstetrics and Gynaecology 687</b></p> <p>Maternal collapse 689</p> <p>Pre‐eclampsia 689</p> <p>Major obstetric haemorrhage 691</p> <p>Amniotic fluid embolism 691</p> <p>Ectopic pregnancy 691</p> <p>Miscarriage 693</p> <p>Hyperemesis gravidarum 694</p> <p>Ovarian cyst accidents 695</p> <p>Pelvic inflammatory disease 697</p> <p>References 697</p> <p><b> </b></p> <p><b>Chapter 88 The Acute Abdomen 699</b></p> <p>History 699</p> <p>Causes of the acute abdomen based on pain location 702</p> <p>Examination 705</p> <p>Investigations 706</p> <p>Onward referral 706</p> <p>References 707</p> <p><b> </b></p> <p><b>Chapter 89 The ABCDE Approach 709</b></p> <p>First steps 709</p> <p>Airway (A) 710</p> <p>Breathing (B) 711</p> <p>Circulation (C) 711</p> <p>Disability (D) 711</p> <p>Exposure (E) 712</p> <p>References 712</p>
<p><b>David M. Taylor, BSc, MSc, PhD, FCMHP, FFRPS, FRPharmS, FRCP (Edin),</b> is Director of Pharmacy and Pathology at the Maudsley Hospital; Professor of Psychopharmacology at King's College, London, UK. <p><b>Fiona Gaughran</b>, <b>MD, FRCP(I), FRCP (Lon), FRCP (Edin), FRCPsych, FHEA,</b> is Director of Research and Development at South London and Maudsley NHS Foundation Trust, where she is Lead Consultant for the National Psychosis Service; Reader in Psychopharmacology and Physical Health at King's College, London, UK. <p><b>Toby Pillinger, MA (Oxon), BM BCh, MRCP, PhD,</b> is an Academic Clinical fellow at the Institute of Psychiatry, Psychology and Neuroscience, King's College, London; South London and Maudsley NHS Foundation Trust, London, UK.
<p><b>Learn to Improve Your Assessment, Investigation, and Management of Physical Health Conditions in People with Severe Mental Illness</b> <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i> offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill. <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i> also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner. <p><i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i> covers the following: <ul> <li>Guidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness</li> <li>Management of physical health emergencies in a psychiatric setting</li> <li>Evidence-based approaches to management of physical side effects of psychiatric medications</li> <li>Advice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity</li> </ul> <p>Perfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, <i>The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry</i> will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.

Diese Produkte könnten Sie auch interessieren:

Small-Animal SPECT Imaging
Small-Animal SPECT Imaging
von: Matthew A. Kupinski, Harrison H. Barrett
PDF ebook
192,59 €
Frontiers in Biochip Technology
Frontiers in Biochip Technology
von: Wan-Li Xing, Jing Cheng
PDF ebook
160,49 €
BioMEMS and Biomedical Nanotechnology
BioMEMS and Biomedical Nanotechnology
von: Mihrimah Ozkan, Mauro Ferrari, Michael Heller
PDF ebook
223,63 €